CVE-2026-41085: Thermo Fisher Scientific Torrent Suite Dx · Improper Privilege Management
Source CVE Database V5
Not known to be exploited · CVSS 8.8 High.
Data as of 26 Oct 2026, 14:05 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 17% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 18 May 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
AI-suggested
Until an official fix is available, restrict access to the affected system to trusted users only and monitor for unusual privilege escalations. Avoid granting unnecessary authenticated access to untrusted users.
Description
Thermo Fisher Scientific Torrent Suite Dx through 5.14.2 has a privilege escalation vulnerability that may allow an authenticated user with limited access privileges to gain unauthorized administrator-level privileges through exploitation of specific system interfaces.